18 and older, any sex, with Community-acquired Pneumonia. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Length of Hospital StayPrimary· duration of hospital stay, an expected average of 4 days
Number of days that the patient stays in hospital was collected from medical record. We have calculated the mean and the standard deviation for both groups.
Group
Value
95% CI
OPEP Therapy Added to Standard Pneumonia Care
1.2
± 0.9
Standard Pneumonia Care
4.0
± 1.2
Reported Dyspnea by Modified-Borg ScoreSecondary· duration of hospital stay, an expected average of 4 days
Dyspnea as measured by modified-Borg score, minimum value 0 (No shortness of breath) and maximum value 10 (Maximal breathlessness). Score scale is from 0-10. We have calculated the mean and the standard deviation for both groups.
Group
Value
95% CI
OPEP Therapy Added to Standard Pneumonia Care
1.2
± 3.8
Standard Pneumonia Care
2.4
± 2.0
Duration of AntibioticsSecondary· duration of hospital stay, an expected average of 4 days
Duration of antibiotics was collected from medical record. We have calculated the mean and the standard deviation for both groups.
Group
Value
95% CI
OPEP Therapy Added to Standard Pneumonia Care
8.8
± 4.5
Standard Pneumonia Care
7.4
± 4.3
Duration of FeverSecondary· duration of hospital stay, an expected average of 4 days
Duration of fever was collected from medical record. We have calculated the mean and the standard deviation for both groups.
Group
Value
95% CI
OPEP Therapy Added to Standard Pneumonia Care
NA
± NA
Standard Pneumonia Care
0.8
± 1.0
Number of Participants With Need for Oxygen Supplement at Hospital DischargeSecondary· duration of hospital stay, an expected average of 4 days
Number of participants with need for oxygen supplement at the time of hospital discharge was collected from medical record for both groups.
Group
Value
95% CI
OPEP Therapy Added to Standard Pneumonia Care
0
Standard Pneumonia Care
0
Reported 30-, 60-, and 90-day Readmission RatesSecondary· 90 day after the hospital discharge
Number of total hospital readmissions post-enrollment was obtained from medical record.
Group
Value
95% CI
OPEP Therapy Added to Standard Pneumonia Care
0
Standard Pneumonia Care
0
Number of Participants With Positive Sputum CultureSecondary· duration of hospital stay, an expected average of 4 days
Data on the diagnosis of organism by sputum (positive sputum culture) was collected from medical record. We have counted number of participants with intervention and without intervention.
Group
Value
95% CI
OPEP Therapy Added to Standard Pneumonia Care
1
Standard Pneumonia Care
3
Number of Participants Transferred to the Intensive Care Unit (ICU)Secondary· duration of hospital stay, an expected average of 4 days
Number of participants transferred to the intensive care unit post enrollment was obtained from medical record for both groups.
Group
Value
95% CI
OPEP Therapy Added to Standard Pneumonia Care
1
Standard Pneumonia Care
1
Sponsor's own description
This is a randomized-controlled prospective study to be conducted at Danbury Hospital and Norwalk Hospital to evaluate oscillatory positive expiratory pressure (OPEP) devices for "airway clearance" (helping to clear out phlegm or mucous from your lungs and bronchial tubes) in the treatment of patients admitted to the hospital with pneumonia.
Approximately 200 subjects are expected to participate in this study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Other recruiting trials for Community-acquired Pneumonia
Currently open trials in the same condition.
NCT07164131 — Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lacta
· Phase 4
· recruiting
NCT06577558 — Efficacy and Safety of SR1375 in Adult Patients With CAP
· Phase 2
· recruiting
NCT06229288 — Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, an
· Phase 3
· recruiting
NCT06125340 — Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Short-course Therapy
· Phase 4
· recruiting
NCT06114888 — Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Novel Diagnostics
· NA
· recruiting
Other Danbury Hospital trials
Trials by the same sponsor.
NCT04687449 — Curcumin in Management of Chronic Obstructive Pulmonary Disease
· NA
· unknown
NCT03870685 — Surgical Site Infiltration of Exparel vs TAP Block With Exparel in Patients Undergoing Laparotomy Via Midline Incision
· Phase 4
· unknown
NCT03930875 — Aspirin Resistance in OSA Patients
· completed
NCT04655443 — Risk Factors That Contribute to the Maintenance of Sinus Rhythm
· terminated
NCT04294303 — Use of Telemonitoring System in Heart Failure Patients
· NA
· completed
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Danbury Hospital
Last refreshed: 24 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04540510.